Back to Search
Start Over
Creatus Biosciences Inc. acquires the exclusive option to IP Assets from Stora Enso to Commercialize Xylitol Bioproduction from Biomass
- Source :
- PR Newswire. October 20, 2021
- Publication Year :
- 2021
-
Abstract
- VANCOUVER, BC, Oct. 20, 2021 /PRNewswire/ - Creatus Biosciences Inc. ('Creatus') have signed a purchase agreement with Virdia, LLC ('Virdia'), a wholly-owned subsidiary of Stora Enso Oyj ('Stora Enso') to [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PR Newswire
- Publication Type :
- News
- Accession number :
- edsgcl.679578835